Navigation Links
Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival,Benefits as Mitigator Against Radiation-Induced Damage in Study

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Some of the factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in our filings with the Securities and Exchange Commission.

     Contacts:

     The Global Consulting Group

     Rachel Levine

     T: (646) 284-9439

     E:
rlevine@hfgcg.com

Cleveland BioLabs, Inc.

CONTACT: Rachel Levine of The Global Consulting Group, +1-646-284-9439,, for Cleveland BioLabs, Inc. rlevine@hfgcg.com

Web site: http://www.cbiolabs.com/

Ticker Symbol: (NASDAQ-NMS:CBLI)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. Cholesterol Drug Fails to Slow Progression of Coronary Disease, Cleveland Clinic Study Reports
2. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
3. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
4. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
5. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
6. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
7. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
8. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
9. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
10. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
11. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy

Post Your Comments:
(Date:11/25/2009)...Nov. 25 Hologic, Inc. (H... developer, manufacturer and supplier of premium d...roducts dedicated to serving the healthcare needs ...logical Society of North America (RSNA) at McCormi...3, 2009 to highlight our new SecurView(®) DX ...
(Date:11/25/2009)...5 BioTrends Research Group, Inc. r...ara report, the first in a multi-phase syndicate...entocor Ortho-Biotech,s Stelara, from product laun...Each wave of the report provides quantitative info...ive information from a subset of 20. The reports ...
(Date:11/25/2009)...if., Nov. 25 AMPAC Fine Chemicals ...ation (Nasdaq: APFC ) announced today that it rec...ability Award at the Annual Statewide Environmenta...s and Technology Association (CMTA), the Industria... Industry Council of California (CICC) held in San...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Medivation Announces Participation in Upcoming Conferences 13928 1Medivation Announces Participation in Upcoming Conferences 13928 2Hyland Software Provides Grant Assistance to Kick Start Technology Projects 13926 1Hyland Software Provides Grant Assistance to Kick Start Technology Projects 13926 2Hyland Software Provides Grant Assistance to Kick Start Technology Projects 13926 3Hyland Software Provides Grant Assistance to Kick Start Technology Projects 13926 4Go Red For Women and NBC Team Up to Help Women Choose to Live 56524 1Go Red For Women and NBC Team Up to Help Women Choose to Live 56524 2Go Red For Women and NBC Team Up to Help Women Choose to Live 56524 3Go Red For Women and NBC Team Up to Help Women Choose to Live 56524 4Go Red For Women and NBC Team Up to Help Women Choose to Live 56524 5
...IN, N.J., July 14 SyntheMed, Inc. (OTC,Bulletin B... development,and commercialization of anti-adhesio...nts, announced today that REPEL-CV(R), the company...uction of adhesions,following cardiac surgery, has...ric patients who undergo open heart surgery. REPEL...
...TAIN VIEW, Calif., July 14 MAP,Pharmaceuticals, I...ted its,Phase 3 clinical program to evaluate MAP00...4 is orally inhaled and self-administered at home ...haler. In the company,s prior Phase,2 efficacy stu...minutes,with relief sustained through at least 24 ...
Other Medicine Technology:SyntheMed Receives Canadian Approval for REPEL-CV(R) 2MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 2MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 3MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 4
(Date:11/27/2009)...has announced that it has become a national sponso...nonprofit organizations dedicated to arthritis res... Delray Beach, FL (Vocus) November 27, ...ompany specializing in the marketing and retail di...nounced today that is has become a national sponso...
(Date:11/27/2009)... Allrecipes.com , the world,s #...ffic numbers, with more than 2.8 million visitors ...ture of what was served on the biggest food holida...09 weighed in at 2,225 calories per serving, a 5 p...to the Allrecipes site, Sweet Potato Pie I stole...
(Date:11/27/2009)...turers who use medical load cells at the heart of ...ringing in technology partner Flintec early in the...medical manufacturers are calling in Flintec load ...s, ensuring that progress will not be constrained ...ed technology. , (PRWEB) ...
(Date:11/26/2009)...wswire/ -- The diabetes population in the United S...d annual medical spending on the disease is projec...y, according to a study published in the December ...Diabetes ® Program (NCDP), a program of Novo ...the University of Chicago. ,, According to the ...
(Date:11/26/2009)... to strains or worse , , THURSDAY, Nov. ...with stuffing your turkey full to bursting, but yo...itcase as you pack for holiday trips. , More th...ital emergency rooms, doctors, offices, clinics an...uries, such as muscle strains, pulls and tears, ac...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Pack Right for the Holidays to Avoid the ER 2
... reported of a recent FDA warning for antibiotics ...ow require a black box warning, the strongest warn...ate due to the greater risk of tendonitis and tend...erything legal on the Internet, reported details o...
...the,Senate, forty-five leading human rights and gl...ress critical shortfalls in legislation that would...(PEPFAR). With the Senate,poised to vote on a five...ssons learned after five years and nearly $20,bill...
...isk, rehospitalization rates, study finds , ... are hospitalized for severe heart failure and hav...e medications while in the hospital, a new study f...the July 15 issue of the Journal of the American ...
...million in cuts, WASHINGTON, July 11 Hundreds of...nt benefits and pay more out of pocket,for health ...re Advantage,plan altogether under legislation app...period, including cutting an,estimated $175 millio...
...ewer side effects, study finds , , FRIDAY,...s say they have developed molecular "smart bombs" ...ing in mice while causing fewer side effects and d...nti-cancer drug delivery system that zooms in on a...
...y of students prefer Mediasite to, podcasting, o...r class, MADISON, Wis., July 11 Sonic Foundry, I... for rich media webcasting and,knowledge managemen...ture capture with Mediasite as an essential part,o...
Other Medicine News:Health News:LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin 2Health News:LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin 3Health News:LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin 4Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 2Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 3Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 4Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 5Health News:Beta Blockers Help Hospitalized Heart Failure Patients 2Health News:Tennessee Seniors' Medicare Advantage Benefits at Risk 2Health News:Nanoparticle Stops Cancer From Spreading 2Health News:Using Mediasite for Lecture Capture Found to Enhance Student Performance at Penn State Milton S. Hershey Medical Center 2Health News:Using Mediasite for Lecture Capture Found to Enhance Student Performance at Penn State Milton S. Hershey Medical Center 3Health News:Using Mediasite for Lecture Capture Found to Enhance Student Performance at Penn State Milton S. Hershey Medical Center 4Health News:Using Mediasite for Lecture Capture Found to Enhance Student Performance at Penn State Milton S. Hershey Medical Center 5
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
Medicine Products: